CoChat

Excitatory GABA: How a Correct Observation May Turn Out to be an Experimental Artifact

Open access
Bregestovski, Piotr, Bernard, Christophe · 2012 · Frontiers in Pharmacology
Cited by 71

The DOI matches its Crossref record; 15 of the 15 references it cites were found in a registry or an index.

Abstract

The concept of an “excitatory/inhibitory switch” of GABA action during development is based on results mainly obtained in brain slices. However, in vivo measurements, as well as observations made in intact in vitro structures, indicate that GABA is inhibitory in rodents at very early neonatal stages. Moreover, providing energy substrates more relevant to the in vivo situation to neonatal brain slices restores the inhibitory action of GABA. These observations question the very concept of depolarizing GABA and suggest that both the “excitatory/inhibitory switch” and the occurrence of Giant Depolarizing Potentials (GDPs) may simply result from cellular injury due to the slicing procedure, leading to energy deficiency and accumulation of intracellular Cl in injured neurons. Brain slices are widely used to investigate basic processes of brain function. Although being a reduced preparation (i.e. there is no blood flow, oxygen levels are non-physiological, most in vivo metabolites are not present in the artificial cerebrospinal fluid (ACSF)) brain slices provide an easier access to cellular phenomena than in vivo models. Many results obtained in vitro (and reproduced by different laboratories) have been verified in vivo, giving ground

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.3389/fphar.2012.00065

Cites

15 of 15 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Cited by

See all 71

Metadata

Authors
Bregestovski, P., & Bernard, C.
Venue
Frontiers in Pharmacology
Published
2012
Volume
3
Pages
65-65
ISSN
1663-9812 (ISSN-L)
OpenAlex
W2120768548
Cited by
71
References
15
FWCI
4.20
Type
journal article
Language
en
Open access
gold

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.